The variables used and equations. by Hoang Thanh Nhon (22311837)

“…The results indicate that incorporating business efficiency scores significantly enhances the models’ accuracy. For example, the deep neural network model shows a decrease in RMSE from 0.926 to 0.375, MAE from 0.337 to 0.196, and MAPE from 134.63 to 114.71. …”

An illustration of how RF works. by Hoang Thanh Nhon (22311837)

“…The results indicate that incorporating business efficiency scores significantly enhances the models’ accuracy. For example, the deep neural network model shows a decrease in RMSE from 0.926 to 0.375, MAE from 0.337 to 0.196, and MAPE from 134.63 to 114.71. …”

The proposed method work-flow. by Hoang Thanh Nhon (22311837)

“…The results indicate that incorporating business efficiency scores significantly enhances the models’ accuracy. For example, the deep neural network model shows a decrease in RMSE from 0.926 to 0.375, MAE from 0.337 to 0.196, and MAPE from 134.63 to 114.71. …”

Image 4_Prediction of major adverse cardiovascular events following ST-segment elevation myocardial infarction using cardiac obesity marker—epicardial adipose tissue mass index: a... by Zeyan Liu (3748747)

“…Background<p>Although reperfusion therapy has led to improvements in the acute phase of ST-segment elevation myocardial infarction (STEMI), the incidence of major adverse cardiovascular events (MACE) following STEMI has not significantly decreased. The accumulation of epicardial adipose tissue (EAT) may be associated with poorer STEMI prognosis and could serve as a potential prognostic marker. …”

Image 2_Prediction of major adverse cardiovascular events following ST-segment elevation myocardial infarction using cardiac obesity marker—epicardial adipose tissue mass index: a... by Zeyan Liu (3748747)

“…Background<p>Although reperfusion therapy has led to improvements in the acute phase of ST-segment elevation myocardial infarction (STEMI), the incidence of major adverse cardiovascular events (MACE) following STEMI has not significantly decreased. The accumulation of epicardial adipose tissue (EAT) may be associated with poorer STEMI prognosis and could serve as a potential prognostic marker. …”

Image 5_Prediction of major adverse cardiovascular events following ST-segment elevation myocardial infarction using cardiac obesity marker—epicardial adipose tissue mass index: a... by Zeyan Liu (3748747)

“…Background<p>Although reperfusion therapy has led to improvements in the acute phase of ST-segment elevation myocardial infarction (STEMI), the incidence of major adverse cardiovascular events (MACE) following STEMI has not significantly decreased. The accumulation of epicardial adipose tissue (EAT) may be associated with poorer STEMI prognosis and could serve as a potential prognostic marker. …”

Image 1_Prediction of major adverse cardiovascular events following ST-segment elevation myocardial infarction using cardiac obesity marker—epicardial adipose tissue mass index: a... by Zeyan Liu (3748747)

“…Background<p>Although reperfusion therapy has led to improvements in the acute phase of ST-segment elevation myocardial infarction (STEMI), the incidence of major adverse cardiovascular events (MACE) following STEMI has not significantly decreased. The accumulation of epicardial adipose tissue (EAT) may be associated with poorer STEMI prognosis and could serve as a potential prognostic marker. …”

Image 3_Prediction of major adverse cardiovascular events following ST-segment elevation myocardial infarction using cardiac obesity marker—epicardial adipose tissue mass index: a... by Zeyan Liu (3748747)

“…Background<p>Although reperfusion therapy has led to improvements in the acute phase of ST-segment elevation myocardial infarction (STEMI), the incidence of major adverse cardiovascular events (MACE) following STEMI has not significantly decreased. The accumulation of epicardial adipose tissue (EAT) may be associated with poorer STEMI prognosis and could serve as a potential prognostic marker. …”

Glucagon-like peptide 1 receptor agonists modestly reduced low-density lipoprotein cholesterol and total cholesterol levels independent of weight reduction: a meta-analysis and met... by Frederick Berro Rivera (12679463)

“…<p>The effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on lipid components are unclear. We aim to quantify the lipid lowering effects of GLP1-RAs.…”

<b>Liraglutide treatment reverses unconventional cellular defects in induced pluripotent stem cell-derived β cells harboring a partially functional </b><b><i>WFS1</i></b><b> varian... by Silvia Torchio (611349)

“…Here, we investigated how the c.316-1G>A and c.757A>T <i>WFS1</i> mutations, which yield partially functional Wolframin, affect the molecular functions of β cells and explored the therapeutic potential of the Glucagon-like peptide 1 receptor (GLP-1R) agonist liraglutide. …”

Data_Sheet_1_Effects of COVID-19-targeted non-pharmaceutical interventions on pediatric hospital admissions in North Italian hospitals, 2017 to 2022: a quasi-experimental study int... by Giuseppe Maglietta (12992976)

“…ITS analysis confirms a high reduction of level change during school closure for Respiratory Diseases (HRR 0.19, 95%CI 0.08–0.47) and a similar but smaller significant reduction when mitigation measures were enacted. …”

Data_Sheet_1_Effects of COVID-19-targeted non-pharmaceutical interventions on pediatric hospital admissions in North Italian hospitals, 2017 to 2022: a quasi-experimental study int... by Giuseppe Maglietta (12992976)

“…ITS analysis confirms a high reduction of level change during school closure for Respiratory Diseases (HRR 0.19, 95%CI 0.08–0.47) and a similar but smaller significant reduction when mitigation measures were enacted. …”

Data Sheet 2_Comparative effectiveness and safety of sodium-glucose cotransporter 2 inhibitors vs glucagon-like peptide 1 receptor agonists in elderly patients with type 2 diabetes... by Yao Wang (102387)

“…Objective<p>This systematic review aimed to evaluate the cardiovascular effectiveness and safety of initiating sodium-glucose cotransporter 2 inhibitors (SGLT2i) in comparison to glucagon-like peptide 1 receptor agonists (GLP-1RA) among elderly patients with diabetes.</p>Methods<p>A comprehensive search of the PubMed, Embase, and Web of Science databases was conducted up to March 2024. …”

Data Sheet 1_Comparative effectiveness and safety of sodium-glucose cotransporter 2 inhibitors vs glucagon-like peptide 1 receptor agonists in elderly patients with type 2 diabetes... by Yao Wang (102387)

“…Objective<p>This systematic review aimed to evaluate the cardiovascular effectiveness and safety of initiating sodium-glucose cotransporter 2 inhibitors (SGLT2i) in comparison to glucagon-like peptide 1 receptor agonists (GLP-1RA) among elderly patients with diabetes.</p>Methods<p>A comprehensive search of the PubMed, Embase, and Web of Science databases was conducted up to March 2024. …”

PRISMA flow chart. by Adeniyi Adeboye (21763205)

“…Additionally, it increased self-efficacy (n = 267; <i>d,</i> 95% CI = 0.22, 0.00 to 0.44) and recovery (n = 285; <i>d,</i> 95% CI = 0.19, -0.02 to 0.41). However, there was a decrease in stigma resistance (n = 318; <i>d</i>, 95% CI = -0.13, -0.36 to 0.10). …”

Characteristics of included studies. by Adeniyi Adeboye (21763205)

“…Additionally, it increased self-efficacy (n = 267; <i>d,</i> 95% CI = 0.22, 0.00 to 0.44) and recovery (n = 285; <i>d,</i> 95% CI = 0.19, -0.02 to 0.41). However, there was a decrease in stigma resistance (n = 318; <i>d</i>, 95% CI = -0.13, -0.36 to 0.10). …”

EPHPP tool quality assessment results. by Adeniyi Adeboye (21763205)

“…Additionally, it increased self-efficacy (n = 267; <i>d,</i> 95% CI = 0.22, 0.00 to 0.44) and recovery (n = 285; <i>d,</i> 95% CI = 0.19, -0.02 to 0.41). However, there was a decrease in stigma resistance (n = 318; <i>d</i>, 95% CI = -0.13, -0.36 to 0.10). …”

Data Sheet 1_Virus-like particles containing the extracellular domain of G protein in combination with a CTL peptide of M2 elicit protection against respiratory syncytial virus inf... by Huan Qin (3511913)

“…Post-RSV challenge, mice vaccinated with G_ECD/M2_82-90-VLPs exhibited a substantially increased proportion of CD25⁺FoxP3⁺ Treg cells and a decreased percentage of Th17 cells in the lungs. …”

Additional within-case comparison information. by Ryan J. Treves (13527735)

“…In 1999, California introduced changes to its clean water program that modified each of these components, and in the present work we explore the impact of these changes using a mixed-methods approach. …”

POTW sample summary. by Ryan J. Treves (13527735)

“…In 1999, California introduced changes to its clean water program that modified each of these components, and in the present work we explore the impact of these changes using a mixed-methods approach. …”